{"transactions":[{"id":4639755,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-10-13T22:10:58.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":12517,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0001213900-26-109155","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026109155/ownership.xml","form_type":"4"}},{"id":4639754,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-13T22:10:58.000Z","date":"2026-10-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":12,"value":120000.0,"ownership":{"direct":false,"nature":"By FMB Research"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-26-109155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026109155/ownership.xml","form_type":"4"}},{"id":4639753,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-13T22:10:58.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":12517,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":12517,"source":{"system":"sec-edgar","filing":"0001213900-26-109155","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026109155/ownership.xml","form_type":"4"}},{"id":4638339,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-09T01:38:59.000Z","date":"2026-10-08","kind":"grant","planned":false,"acquired":true,"shares":5636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":5636,"derivative":{"exercise_price":12,"expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":5636},"source":{"system":"sec-edgar","filing":"0001213900-26-108188","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026108188/ownership.xml","form_type":"4"}},{"id":728790,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728789,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728788,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728787,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":536097,"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":784550,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:17.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001273885-26-000002","document":"form4-05112026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000127388526000002/form4-05112026_040505.xml","form_type":"4"}},{"id":784549,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:17.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":22.8,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001273885-26-000002","document":"form4-05112026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000127388526000002/form4-05112026_040505.xml","form_type":"4"}},{"id":784548,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:17.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an \"In-the-Money Option\") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money\nOption, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":4.46,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001273885-26-000002","document":"form4-05112026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000127388526000002/form4-05112026_040505.xml","form_type":"4"}},{"id":784547,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:17.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each Company Stock Option that had a per share exercise price less than the Cash Amount (an \"In-the-Money Option\") was automatically cancelled and converted at the Effective Time into the right to receive (A) an amount in cash, without interest, equal to the product obtained by multiplying (x) the excess of the Cash Amount over the exercise price per share underlying such Company Stock Option at the Effective Time by (y) the number of shares underlying such In-the-Money\nOption, subject to the terms and conditions specified in the Merger Agreement and (B) one CVR in respect of each share underlying such In-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001273885-26-000002","document":"form4-05112026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000127388526000002/form4-05112026_040505.xml","form_type":"4"}},{"id":784546,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-11T20:30:17.000Z","date":"2026-05-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to acquire shares of Issuer common stock (the \"Company Stock Options\") that had a per share exercise price equal to or greater than the Cash Amount (an \"Out-of-the-Money Option\"), was automatically cancelled and ceased to exist at the Effective Time, and no consideration was delivered in exchange for such Out-of-the-Money Option."}],"balance_after":0,"derivative":{"exercise_price":26.4,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001273885-26-000002","document":"form4-05112026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000127388526000002/form4-05112026_040505.xml","form_type":"4"}},{"id":784545,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T20:30:17.000Z","date":"2026-05-11","kind":"other","planned":false,"acquired":false,"shares":89069,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), by and among the Issuer, Aurinia Pharma U.S., Inc. (\"Parent\") and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc.,\n(\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the \"Cash Consideration\"); plus (ii) one non-tradable contingent value right (each, a \"CVR\"), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"CVR Agreement\")"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) without interest and less any applicable tax withholding, upon the achievement of specified milestones in accordance with the terms and subject to the conditions of a CVR Agreement with Broadridge Corporate Issuer Solutions, LLC, as the rights agent. After completion of the tender offer, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of May 11, 2026, with the Issuer continuing as the surviving entity and a wholly owned subsidiary of\nParent (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of March 30, 2026 (the \"Merger Agreement\"), by and among the Issuer, Aurinia Pharma U.S., Inc. (\"Parent\") and Parent's direct wholly owned subsidiary, Aurinia Merger Sub, Inc.,\n(\"Purchaser\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock. In exchange for each share, tendering stockholders received: (i) $6.955 per share in cash, without interest and less any applicable tax withholding (the \"Cash Consideration\"); plus (ii) one non-tradable contingent value right (each, a \"CVR\"), which represents the right to receive certain payments in cash in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"CVR Agreement\")"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001273885-26-000002","document":"form4-05112026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000127388526000002/form4-05112026_040505.xml","form_type":"4"}},{"id":1018417,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-10-15T12:01:44.000Z","date":"2025-10-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":784404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 9, 2025, pursuant to that certain Business Combination Agreement, dated July 13, 2025 (as amended by the Amendment Agreement, dated September 23, 2025, the \"Agreement\"), by and among the Issuer, XenoTherapeutics, Inc., Xeno Acquisition Corp. (\"Purchaser\") and XOMA Royalty Corporation, the Purchaser acquired all of the issued and outstanding common shares of the Issuer for (i) cash consideration of approximately US$0.12 per share and (ii) one contingent value right (\"CVR\") for each common share entitling its holder to receive up to approximately US$0.14 per CVR and payable within specified periods following the close of the transactions contemplated by the Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-099655","document":"tm2528208-5_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000110465925099655/tm2528208-5_4seq.xml","form_type":"4"}},{"id":1102557,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102556,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102555,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102554,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":506497,"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1103589,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T21:00:08.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/18/2026, subject to Reporting Person continuing to provide service through such date."}],"balance_after":5000,"derivative":{"exercise_price":4.46,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-25-017966","document":"form4-06232025_050604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000141588925017966/form4-06232025_050604.xml","form_type":"4"}},{"id":1299896,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T19:30:36.000Z","date":"2025-01-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.3614,"value":33614.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.32 to $3.405. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This Form 4/A has been filed solely to change the code reported in Column 4 of Table I of the Reporting Person's Form 4 filed on January 17, 2025, which had inadvertently noted a \"D\" instead of \"A\" to reflect an acquisition of the common stock of Atea Pharmaceuticals, Inc. (the \"Company\"), due to an administrative error."}],"balance_after":476897,"source":{"system":"sec-edgar","filing":"0000950170-25-006589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025006589/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-17"}},{"id":1299895,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T19:30:36.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":3.1923,"value":47884.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.165 to $3.21. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This Form 4/A has been filed solely to change the code reported in Column 4 of Table I of the Reporting Person's Form 4 filed on January 17, 2025, which had inadvertently noted a \"D\" instead of \"A\" to reflect an acquisition of the common stock of Atea Pharmaceuticals, Inc. (the \"Company\"), due to an administrative error."}],"balance_after":466897,"source":{"system":"sec-edgar","filing":"0000950170-25-006589","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025006589/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-17"}},{"id":1299894,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T13:03:19.000Z","date":"2025-01-16","kind":"purchase","planned":false,"acquired":false,"shares":10000,"price":3.3614,"value":33614.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.32 to $3.405. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":476897,"source":{"system":"sec-edgar","filing":"0000950170-25-006489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025006489/ownership.xml","form_type":"4"}},{"id":1299893,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T13:03:19.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":false,"shares":15000,"price":3.1923,"value":47884.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.165 to $3.21. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":466897,"source":{"system":"sec-edgar","filing":"0000950170-25-006489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025006489/ownership.xml","form_type":"4"}},{"id":1333666,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-12T23:00:03.000Z","date":"2024-12-10","kind":"sale","planned":false,"acquired":false,"shares":359606,"price":2.8461,"value":1023474.6366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.955. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":451897,"source":{"system":"sec-edgar","filing":"0000950170-24-135930","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017024135930/ownership.xml","form_type":"4"}},{"id":1471907,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T22:08:49.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.44,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-24-076394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017024076394/ownership.xml","form_type":"4"}},{"id":1471906,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-21T22:08:49.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-24-076394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017024076394/ownership.xml","form_type":"4"}},{"id":1471899,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:20:14.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/20/2025, subject to Reporting Person continuing to provide service through such date."}],"balance_after":50000,"derivative":{"exercise_price":0.67,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-017836","document":"form4-06212024_040602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000141588924017836/form4-06212024_040602.xml","form_type":"4"}},{"id":1475019,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-18T21:00:11.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":false,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units do not have an expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000950170-24-074987","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017024074987/ownership.xml","form_type":"4"}},{"id":1475018,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T21:00:11.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":811503,"source":{"system":"sec-edgar","filing":"0000950170-24-074987","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017024074987/ownership.xml","form_type":"4"}},{"id":1558406,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true}}],"security":"Options","published_at":"2024-03-28T12:32:28.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":9.04,"exercise_date":"2025-03-25","expiration_date":"2034-03-25","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950172-24-000133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000095017224000133/form4.xml","form_type":"4"}},{"id":1669617,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:39:15.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.44,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001999371-24-000962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000962/ownership.xml","form_type":"4"}},{"id":1669616,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:39:15.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":15.91,"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001999371-24-000962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000962/ownership.xml","form_type":"4"}},{"id":1669615,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:39:15.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.21,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001999371-24-000962","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000962/ownership.xml","form_type":"4"}},{"id":1669614,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-01-26T16:39:15.000Z","date":"2024-01-26","kind":"other","planned":false,"acquired":false,"shares":1005207,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001999371-24-000962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000962/ownership.xml","form_type":"4"}},{"id":1731199,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-22T18:22:47.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":23259,"price":5.73,"value":133274.07,"ownership":{"direct":true},"balance_after":784404,"source":{"system":"sec-edgar","filing":"0000950170-23-065921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000095017023065921/ownership.xml","form_type":"4"}},{"id":1739031,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-16T17:45:43.000Z","date":"2023-11-03","kind":"purchase","planned":false,"acquired":true,"shares":16471,"price":5.99,"value":98661.29,"ownership":{"direct":true},"balance_after":760875,"source":{"system":"sec-edgar","filing":"0000950170-23-064584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000095017023064584/ownership.xml","form_type":"4"}},{"id":1739030,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-16T17:45:43.000Z","date":"2023-11-02","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":5.35,"value":321000.0,"ownership":{"direct":true},"balance_after":744404,"source":{"system":"sec-edgar","filing":"0000950170-23-064584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000095017023064584/ownership.xml","form_type":"4"}},{"id":1809958,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T21:14:30.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 35,000 shares of the Issuer's common stock, which will vest in full on the date of the 2024 Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":35000,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-23-090704","document":"tm2323614-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465923090704/tm2323614-8_4seq1.xml","form_type":"4"}},{"id":1822751,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:56:39.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919123043423/doc4.xml","form_type":"4"}},{"id":1822750,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:56:39.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919123043423/doc4.xml","form_type":"4"}},{"id":1822749,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:56:39.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":26000,"derivative":{"exercise_price":2.28,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919123043423/doc4.xml","form_type":"4"}},{"id":1822748,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-26T20:56:39.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 24, 2023, the option originally granted to the Reporting Person was amended to reduce the exercise price to $2.28 per share. All of the other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.59,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-043423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919123043423/doc4.xml","form_type":"4"}},{"id":1847669,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T20:05:23.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":46750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":46750,"derivative":{"exercise_price":4.12,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":46750},"source":{"system":"sec-edgar","filing":"0000899243-23-016131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000089924323016131/doc4.xml","form_type":"4"}},{"id":1847668,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-21T20:05:23.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":33150,"derivative":{"underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000899243-23-016131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000089924323016131/doc4.xml","form_type":"4"}},{"id":1851860,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:38:33.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/15/2024, subject to Reporting Person continuing to provide service through such date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-037931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919123037931/doc4.xml","form_type":"4"}},{"id":1854109,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T22:05:46.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":1.18,"expiration_date":"2023-06-12","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-037516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919123037516/doc4.xml","form_type":"4"}},{"id":2062649,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":34334,"price":2.42,"value":83088.28,"ownership":{"direct":true},"balance_after":684404,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2062648,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":37889,"price":2.41,"value":91312.49,"ownership":{"direct":true},"balance_after":718738,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2062647,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":43617,"price":2.53,"value":110351.01,"ownership":{"direct":true},"balance_after":756627,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2062646,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":50000,"price":2.67,"value":133500.0,"ownership":{"direct":true},"balance_after":800244,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2062645,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":50000,"price":2.86,"value":143000.0,"ownership":{"direct":true},"balance_after":850244,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2062644,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":32000,"price":2.9,"value":92800.0,"ownership":{"direct":true},"balance_after":900244,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2062643,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-01-05T15:41:59.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":25000,"price":3,"value":75000.0,"ownership":{"direct":true},"balance_after":932244,"source":{"system":"sec-edgar","filing":"0000899243-23-000914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000089924323000914/doc4.xml","form_type":"4"}},{"id":2105332,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T17:45:30.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":77000,"price":8.27,"value":636790.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.91 to $8.4947. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1005207,"source":{"system":"sec-edgar","filing":"0001104659-22-121849","document":"tm2231304-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465922121849/tm2231304-1_4seq1.xml","form_type":"4"}},{"id":2105331,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-23T17:45:30.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":45000,"price":7.8,"value":351000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $7.4181 to $8.0295. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":928207,"source":{"system":"sec-edgar","filing":"0001104659-22-121849","document":"tm2231304-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465922121849/tm2231304-1_4seq1.xml","form_type":"4"}},{"id":2115967,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-16T01:00:11.000Z","date":"2022-11-14","kind":"sale","acquired":false,"shares":16166,"price":5.156,"value":83351.896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1000 to $5.2242, inclusive."}],"balance_after":778353,"source":{"system":"sec-edgar","filing":"0000899243-22-035942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000089924322035942/doc4.xml","form_type":"4"}},{"id":2115966,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-16T01:00:11.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":25500,"price":5.1503,"value":131332.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1200 to $5.1947, inclusive."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":794519,"source":{"system":"sec-edgar","filing":"0000899243-22-035942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000089924322035942/doc4.xml","form_type":"4"}},{"id":2118034,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-14T16:17:26.000Z","date":"2022-11-08","kind":"purchase","acquired":true,"shares":42881,"price":5.83,"value":249996.23,"ownership":{"direct":true},"balance_after":883207,"source":{"system":"sec-edgar","filing":"0000899243-22-035691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322035691/doc4.xml","form_type":"4"}},{"id":2128439,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-01T11:04:14.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vest after 12 months from the date of grant."}],"balance_after":22500,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-29","underlying":"Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-22-054966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919122054966/doc4.xml","form_type":"4"}},{"id":2178321,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-19T17:43:32.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's common stock, which will vest in full on June 1, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20000,"derivative":{"exercise_price":2.44,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-029323","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322029323/doc4.xml","form_type":"4"}},{"id":2225215,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T23:48:40.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":61264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":61264,"derivative":{"exercise_price":6.5,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":61264},"source":{"system":"sec-edgar","filing":"0000899243-22-023504","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000089924322023504/doc4.xml","form_type":"4"}},{"id":2227342,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T22:01:49.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/16/2023, subject to Reporting Person continuing to provide service through such date."}],"balance_after":26000,"derivative":{"exercise_price":4.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-22-038043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919122038043/doc4.xml","form_type":"4"}},{"id":2235716,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T22:40:33.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":2.09,"expiration_date":"2032-06-07","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-036096","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919122036096/doc4.xml","form_type":"4"}},{"id":2321326,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T21:45:52.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":20000,"price":14.77,"value":295400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.44 to $15.00 inclusive."}],"balance_after":890691,"source":{"system":"sec-edgar","filing":"0001209191-22-020584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919122020584/doc4.xml","form_type":"4"}},{"id":2321325,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T21:45:52.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":45000,"price":17,"value":765000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.885 to $17.01 inclusive."}],"balance_after":870691,"source":{"system":"sec-edgar","filing":"0001209191-22-020584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919122020584/doc4.xml","form_type":"4"}},{"id":2321324,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T21:45:52.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":15000,"price":15.96,"value":239400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.47 to\n$16.36 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3)."}],"balance_after":825691,"source":{"system":"sec-edgar","filing":"0001209191-22-020584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919122020584/doc4.xml","form_type":"4"}},{"id":2560756,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-23T20:26:30.000Z","date":"2021-09-22","kind":"exercise","acquired":false,"shares":8896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-hundred percent (100%) of the shares subject to the option vested on 6/24/2021."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-21-057418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121057418/doc4.xml","form_type":"4"}},{"id":2560755,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-23T20:26:30.000Z","date":"2021-09-21","kind":"exercise","acquired":false,"shares":8896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-hundred percent (100%) of the shares subject to the option vested on 6/25/2020."}],"balance_after":0,"derivative":{"exercise_price":7.63,"expiration_date":"2029-06-25","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-21-057418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121057418/doc4.xml","form_type":"4"}},{"id":2560754,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-23T20:26:30.000Z","date":"2021-09-21","kind":"exercise","acquired":false,"shares":8896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option vested on 1/1/2019."}],"balance_after":0,"derivative":{"exercise_price":5.91,"expiration_date":"2028-04-16","underlying":"Common Stock","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001209191-21-057418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121057418/doc4.xml","form_type":"4"}},{"id":2560753,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:26:30.000Z","date":"2021-09-22","kind":"exercise","acquired":true,"shares":8896,"price":5.6,"value":49817.6,"ownership":{"direct":true},"balance_after":810691,"source":{"system":"sec-edgar","filing":"0001209191-21-057418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121057418/doc4.xml","form_type":"4"}},{"id":2560752,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:26:30.000Z","date":"2021-09-21","kind":"exercise","acquired":true,"shares":8896,"price":7.63,"value":67876.48,"ownership":{"direct":true},"balance_after":801795,"source":{"system":"sec-edgar","filing":"0001209191-21-057418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121057418/doc4.xml","form_type":"4"}},{"id":2560751,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T20:26:30.000Z","date":"2021-09-21","kind":"exercise","acquired":true,"shares":8896,"price":5.91,"value":52575.36,"ownership":{"direct":true},"balance_after":792899,"source":{"system":"sec-edgar","filing":"0001209191-21-057418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121057418/doc4.xml","form_type":"4"}},{"id":2561003,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-23T17:21:30.000Z","date":"2021-09-21","kind":"purchase","acquired":true,"shares":3786,"price":14.3,"value":54139.8,"ownership":{"direct":true},"balance_after":840326,"source":{"system":"sec-edgar","filing":"0000899243-21-037351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321037351/doc4.xml","form_type":"4"}},{"id":2649636,"issuer":{"id":12111,"kind":"organization","name":"Kezar Life Sciences, Inc.","symbol":"KZR"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T22:45:48.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-hundred percent (100%) of the shares subject to the option shall vest on 6/28/2022, subject to Reporting Person continuing to provide service through such date."}],"balance_after":26000,"derivative":{"exercise_price":5.59,"expiration_date":"2031-06-27","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-21-044078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121044078/doc4.xml","form_type":"4"}},{"id":2660598,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T21:34:55.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":34025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":34025,"derivative":{"exercise_price":23.39,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":34025},"source":{"system":"sec-edgar","filing":"0000899243-21-025044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000089924321025044/doc4.xml","form_type":"4"}},{"id":2671652,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T20:34:11.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-06-08","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-039847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000120919121039847/doc4.xml","form_type":"4"}},{"id":2708266,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T17:46:40.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 24,000 shares of the Issuer's common stock, which will vest in equal monthly installments through May 14, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":24000,"derivative":{"exercise_price":15.33,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000899243-21-019789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321019789/doc4.xml","form_type":"4"}},{"id":2738571,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-04-27T17:05:45.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":578397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":535601},"source":{"system":"sec-edgar","filing":"0000899243-21-017113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017113/doc4.xml","form_type":"4"}},{"id":2738570,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-27T17:05:45.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":189998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":175939},"source":{"system":"sec-edgar","filing":"0000899243-21-017113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017113/doc4.xml","form_type":"4"}},{"id":2738569,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:05:45.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":535601,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":836540,"source":{"system":"sec-edgar","filing":"0000899243-21-017113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017113/doc4.xml","form_type":"4"}},{"id":2738568,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:05:45.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":175939,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":300939,"source":{"system":"sec-edgar","filing":"0000899243-21-017113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017113/doc4.xml","form_type":"4"}},{"id":2738567,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:05:45.000Z","date":"2021-04-23","kind":"purchase","acquired":true,"shares":5000,"price":15.78,"value":78900.0,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0000899243-21-017113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017113/doc4.xml","form_type":"4"}},{"id":2738566,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:05:45.000Z","date":"2021-04-23","kind":"purchase","acquired":true,"shares":120000,"price":17,"value":2040000.0,"ownership":{"direct":true},"balance_after":120000,"source":{"system":"sec-edgar","filing":"0000899243-21-017113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017113/doc4.xml","form_type":"4"}},{"id":2745447,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:42:33.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":4.14,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-027415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027415/doc4.xml","form_type":"4"}},{"id":2745446,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:42:33.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":6.09,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-027415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027415/doc4.xml","form_type":"4"}},{"id":2745445,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:42:33.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":17.27,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-027415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027415/doc4.xml","form_type":"4"}},{"id":2745444,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:42:33.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":29.8,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-027415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027415/doc4.xml","form_type":"4"}},{"id":2745443,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-19T19:42:33.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, immediately prior to the effective time of the Merger, each option to purchase shares of Common Stock granted by the Company that was then outstanding and unexercised was cancelled and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of Common Stock subject to such option multiplied by (y) the excess, if any, of (A) the Offer Price minus (B) the exercise price payable per share under such option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_price":22.15,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-027415","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027415/doc4.xml","form_type":"4"}},{"id":2745442,"issuer":{"id":16595,"kind":"organization","name":"FIVE PRIME THERAPEUTICS, INC.","symbol":"FPRX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T19:42:33.000Z","date":"2021-04-16","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":38,"value":190000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated March 4, 2021 (the \"Merger Agreement\"), by and among the Five Prime Therapeutics, Inc. (the \"Company\"), Amgen Inc. (\"Parent\") and Franklin Acquisition Sub, Inc., a wholly owned subsidiary of Parent (\"Purchaser\"), Purchaser merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the \"Merger\"), effective as of April 16, 2021. Pursuant to the Merger Agreement, each issued and outstanding share of common stock of the Company, par value $0.001 per share (\"Common Stock\"), was converted into the right to receive $38.00 per share (the \"Offer Price\") in cash, without interest, minus any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-027415","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175505/000120919121027415/doc4.xml","form_type":"4"}},{"id":2808803,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-03-04T18:47:02.000Z","date":"2021-02-22","kind":"purchase","acquired":true,"shares":57000,"price":27,"value":1539000.0,"ownership":{"direct":true},"balance_after":957244,"source":{"system":"sec-edgar","filing":"0001209191-21-017990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121017990/doc4.xml","form_type":"4"}},{"id":2895166,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-26T19:01:10.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant."}],"balance_after":16500,"derivative":{"exercise_price":7,"expiration_date":"2030-12-11","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-21-005508","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121005508/doc4a.xml","form_type":"4/A","original_submission_date":"2021-01-11"}},{"id":2910981,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest after 12 months from the date of grant, and the remaining 75% vest in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting on every one month anniversary thereafter."}],"balance_after":16500,"derivative":{"exercise_price":7,"expiration_date":"2030-12-11","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910980,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":6773,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18227,"derivative":{"exercise_price":4.67,"exercise_date":"2022-11-30","expiration_date":"2029-10-30","underlying":"Common Shares","underlying_shares":6773},"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910979,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.23,"exercise_date":"2023-11-04","expiration_date":"2029-10-04","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910978,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":2184,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2816,"derivative":{"exercise_price":3.81,"exercise_date":"2023-03-08","expiration_date":"2029-02-08","underlying":"Common Shares","underlying_shares":2184},"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910977,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":6534,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2966,"derivative":{"exercise_price":4,"exercise_date":"2022-03-21","expiration_date":"2028-02-21","underlying":"Common Shares","underlying_shares":6534},"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910976,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":1716,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":784,"derivative":{"exercise_price":4,"exercise_date":"2022-03-21","expiration_date":"2025-03-05","underlying":"Common Shares","underlying_shares":1716},"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910975,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":6773,"price":4.67,"value":31629.91,"ownership":{"direct":true},"balance_after":900244,"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}},{"id":2910974,"issuer":{"id":15763,"kind":"organization","name":"ESSA Pharma Inc.","symbol":"EPIX"},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-01-11T16:42:46.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":25000,"price":3.23,"value":80750.0,"ownership":{"direct":true},"balance_after":893471,"source":{"system":"sec-edgar","filing":"0001209191-21-002944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1633932/000120919121002944/doc4.xml","form_type":"4"}}],"next_cursor":"2021-01-11T16:42:46.000000Z,2910974"}